Will a new imaging tool fit the clinical workflow?
An imaging team sees promise in a new analysis tool. Before it considers adoption, it needs to see how clinicians use the output and where the review adds work.

Who owns the decision?
Start with the clinical service lead and the imaging operations manager. Include the intended users, IT and data governance when defining an evaluation.
What evidence should you bring?
Bring the intended use, a representative output, the current reading workflow and known limitations. Agree on how to measure reading time, agreement between readers and cases that require review.
What should the first commitment be?
Scope a retrospective, non-clinical workflow evaluation using appropriately approved data. Establish the review criteria and decision owner before discussing wider deployment.
Industry reference
FDA’s human factors guidance emphasizes intended users, uses and use environments. Those distinctions make an early workflow discussion more precise.
FDA human factors guidanceBring us your buyer question.
Tell Kimmo what you can demonstrate, who might use it and what commercial decision you want to reach.
Email Kimmo about this sector Opens your email app.